Adjuvant chemotherapy for colon cancer: a consensus statement of the Hellenic and Cypriot Colorectal Cancer Study Group by the HeSMO

Colorectal cancer remains a major cause of cancer mortality in the Western world both in men and women. In this manuscript a concise overview and recommendations on adjuvant chemotherapy in colon cancer are presented. An executive team from the Hellenic Society of Medical Oncology was assigned to develop a consensus statement and guidelines on the adjuvant treatment of colon cancer. Fourteen statements on adjuvant treatment were subjected to the Delphi methodology. Voting experts were 68. All statements achieved a rate of consensus above than 80%  (>87%) and none revised and entered to a second round of voting. Th ree and 8 of them achieved a 100 and an over than 90% consensus, respectively. Th ese statements describe evaluations of therapies in clinical practice. Th ey could be considered as general guidelines based on best available evidence for assistance in treatment decision-making. Furthermore, they serve to identify questions and targets for further research and the settings in which investigational therapy could be considered.Keywords Colon cancer, adjuvant chemotherapy, guidelines, Hellas, CyprusAnn Gastroenterol 2016; 29 (1): 18-23